AISAP Overview
AISAP supports clinicians using point-of-care ultrasound with real-time acquisition guidance, immediate interpretation, and multi-organ diagnoses, leading to exceptional clinical outcomes and health care efficiency. AISAP developed POCAD, an intuitive, easy-to-use, secure cloud-based platform that provides AI-powered ultrasound diagnosis anywhere and at any time, designed to empower clinicians and connect care teams to provide immediate, efficient, and fast treatment, right at the patient's bedside. POCAD is a deep-learning, secure, cloud-based platform that provides real-time analysis of images and data from any ultrasound device, assesses the patient’s condition, and predicts patient outcomes. AISAP’s CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software received FDA clearance.
Cumulative Funding Raised Over Time ($)
—Feb 2022
$13.0MMay 2024
Latest News
AISAP Named to Fast Company’s List of the World’s Most Innovative Companies of 2025
הישג עולמי ל-AISAP: הסטארט-אפ נבחר לאחת החברות החדשניות והמבטיחות בעולם לשנת 2025
growth-positive
Startup Gets FDA Approval For Cardiac Ultrasound Software
Medtech startup AISAP has received FDA approval for its CARDIO point-of-care ultrasound (POCUS) platform, which provides automatic analyses, interpretations, and reports for heart disease patients. The platform can diagnose up to 90% of common cardiac parameters within minutes and has been validated through extensive clinical trials at institutions like Mass General Brigham and the Mayo Clinic. This FDA clearance makes AISAP the first company to secure approval in the CADx pathway for comprehensive structural heart disease diagnosis using POCUS. The approval is expected to significantly enhance the scalability and accessibility of cardiac diagnostics.
Customers
growth-positive
AISAP receives FDA approval for cardiac ultrasound software platform | CTech
AISAP, a developer of AI-powered Point-of-Care Assisted Diagnosis (POCAD) solutions, has received 510(k) clearance from the U.S. FDA for its AISAP CARDIO point-of-care ultrasound (POCUS) software platform. This platform, developed in collaboration with Sheba Medical Centers ARC Innovation Center, integrates multiple diagnostic modules into a comprehensive cardiac ultrasound package. Earlier this year, AISAP raised $13 million in Seed funding led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P. The platform has been validated through extensive clinical trials at several renowned medical institutions. This FDA clearance marks a significant milestone for AISAP, positioning it as a leader in AI-driven cardiac diagnostics.
InvestmentCustomers
growth-positive
AISAP raises $13 Million in Seed for its AI ultrasound solution | CTech
AISAP, a company developing an AI-powered Point Of Care Assisted Diagnosis (POCAD) solution for the medical ultrasound industry, has raised $13 million in Seed funding. The round was led by Harel Insurance Investments & Financial Services Ltd., and Shoni Top Ventures, L.P. AISAP’s POCAD solution provides AI-powered diagnoses that are accurate and easy to understand for physicians. The company claims its solution can provide a full analysis and diagnosis in as little as 5 minutes. AISAP’s algorithms have been trained on more than 300,000 studies made up of more than 24 million video clips.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $13M |
| Last funding | $13M |
| Stage | Seed |
| Rounds | 2 |
| Investors | 2 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | www.aisap.ai/ |
Locations
Derech Sheba 2, Ramat Gan, Israel
Photos & Videos
1 item(s)
AISAP Business
Business models
B2B
Product stage
Beta
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Platforms & InterfacesSoftwareArtificial IntelligenceDeep LearningSimulation & ImagingUltrasoundTags (11)
ultrasoundheart-failureobesityvalvesvascularimagingdiagnosticsdigital-healthcareartificial-intelligenceheart-diseasesmedical-devicesAISAP Financials
$13M
Total funding
Undisclosed
Capital raised
$13M
Last funding
Seed
Funding stage
2
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
—Feb 2022
$13.0MMay 2024
Private Equity Funding
Seed
May 2024
$13M
Shoni Health Ventures (Lead), Harel Insurance & Finance (Lead)
Seed
Feb 2022
Undisclosed
Harel Insurance & Finance (Lead)
,
Shoni Health Ventures
AISAP Lifecycle
Cumulative Funding Raised Over Time
—Feb 2022
$13.0MMay 2024
All Events
Seed
May 2024
$13M
Shoni Health Ventures (Lead), Harel Insurance & Finance (Lead)
Seed
Feb 2022
Undisclosed
Harel Insurance & Finance (Lead)
,
Shoni Health Ventures
AISAP News
13 articlesAISAP Named to Fast Company’s List of the World’s Most Innovative Companies of 2025
הישג עולמי ל-AISAP: הסטארט-אפ נבחר לאחת החברות החדשניות והמבטיחות בעולם לשנת 2025
growth-positive
Startup Gets FDA Approval For Cardiac Ultrasound Software
Medtech startup AISAP has received FDA approval for its CARDIO point-of-care ultrasound (POCUS) platform, which provides automatic analyses, interpretations, and reports for heart disease patients. The platform can diagnose up to 90% of common cardiac parameters within minutes and has been validated through extensive clinical trials at institutions like Mass General Brigham and the Mayo Clinic. This FDA clearance makes AISAP the first company to secure approval in the CADx pathway for comprehensive structural heart disease diagnosis using POCUS. The approval is expected to significantly enhance the scalability and accessibility of cardiac diagnostics.
Customers
growth-positive
AISAP receives FDA approval for cardiac ultrasound software platform | CTech
AISAP, a developer of AI-powered Point-of-Care Assisted Diagnosis (POCAD) solutions, has received 510(k) clearance from the U.S. FDA for its AISAP CARDIO point-of-care ultrasound (POCUS) software platform. This platform, developed in collaboration with Sheba Medical Centers ARC Innovation Center, integrates multiple diagnostic modules into a comprehensive cardiac ultrasound package. Earlier this year, AISAP raised $13 million in Seed funding led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P. The platform has been validated through extensive clinical trials at several renowned medical institutions. This FDA clearance marks a significant milestone for AISAP, positioning it as a leader in AI-driven cardiac diagnostics.
InvestmentCustomers
growth-positive
AISAP raises $13 Million in Seed for its AI ultrasound solution | CTech
AISAP, a company developing an AI-powered Point Of Care Assisted Diagnosis (POCAD) solution for the medical ultrasound industry, has raised $13 million in Seed funding. The round was led by Harel Insurance Investments & Financial Services Ltd., and Shoni Top Ventures, L.P. AISAP’s POCAD solution provides AI-powered diagnoses that are accurate and easy to understand for physicians. The company claims its solution can provide a full analysis and diagnosis in as little as 5 minutes. AISAP’s algorithms have been trained on more than 300,000 studies made up of more than 24 million video clips.
Investment
growth-positive
סיליקון קלאב: AISAP מפתחת מכשיר בדיקה ללב מבוסס בינה מלאכותית - Chiportal
AISAP, led by Adiel Am-Shalom, is developing an AI-based solution to streamline and make more accessible the performance of echocardiograms. The solution allows doctors to perform ultrasound scans of the heart themselves, without the need for an echo lab or an expert to interpret the results. The system has been used at Sheba Hospital, where about 2,400 patients were scanned in the last six months. The results show that in 53% of cases a problem requiring intervention was identified, and in about half of the cases the clinical diagnosis changed following the echo test.
CustomersPartnersExpand
growth-positive
טכנולוגיה חדשה: אולטרסאונד שמפענח מחלות לבביות באמצעות AI
כמה בתי חולים בישראל כבר רכשו את התוכנה שמאבחנת בעצמה בדיקת אקו לב באמצעות AI. הטכנולוגיה תאפשר לבצע יותר בדיקות ולהציל יותר חולים
Israeli company AISAP has developed an artificial intelligence technology that allows for quick interpretation of echocardiogram tests. The technology enables doctors to receive rapid results within seconds, potentially saving more lives by conducting more echocardiogram tests. The technology has been purchased by several hospitals in Israel and is awaiting approval from the US Food and Drug Administration (FDA).
Customers
הבינה המלאכותית שמסייעת לטיפול בחיילים הפצועים
הפיתוח של חברת AISAP מאפשר לרופאים הצבאיים בשטח לקבל פיענוח מיידי של בדיקות אולטרסאונד לב מהשטח הישר לטלפון הנייד • הוא היה בשימוש נסיוני בבית החולים שיבא אך הושמש לצרכים צבאיים מוקדם מהצפוי בשל המלחמה • "הפיתוח מיועד לתת לרופאים בשטח פרמטרים שבדיקה בסטטוסקופ לא יכולה לתת", אומר המייסד
growth-positive
Israeli startup uses AI to help doctors image and diagnose cardiac issues in minutes
Physician-entrepreneurs at Sheba Medical Center have developed AISAP, a product that uses AI to diagnose cardiac problems. The product, which can be used by all doctors, not just cardiologists, requires a handheld ultrasound probe and a digital tablet. The AI-driven diagnosis can be made on the spot, potentially saving lives. The product is designed to evaluate the quality of images from two required scan points and interpret information about eight critical heart functions. The images are sent to the secure AISAP cloud-based platform for analysis and the results are sent back to the tablet almost immediately.
CustomersExpand
Israeli AISAP Rapid Cardiac Diagnosis Can Save Lives with Handheld Scanner and Tablet
growth-positive
10 Israeli companies selected for Assuta's 'RISE With US' program | CTech
Assuta Medical Centers innovation arm, Rise, has announced the 10 startups selected for its RISE with US program. The program aims to connect startups to the global healthcare market, with a focus on the American market. The startups, selected from 111 applicants, are developing digital health solutions using artificial intelligence and big data. The program is supported by AWS and Nvidia, as well as venture capital funds LionBird and eHealth Ventures. The startups will have access to Assuta Medical Centers, receive clinical guidance from physicians, and gain access to a network of contacts in the healthcare industry.
PartnersInvestment
growth-positive
17 SMEs JOIN THE 2023 MEET&MATCH.DX COHORT
Interreg NWE Codex4SMEs has announced the selection of 17 companies for the second edition of its Meet&Match.Dx program. The program connects SMEs producing innovative diagnostic solutions with leading European MedTech corporations. The selected startups will participate in modules including pitch training, expert access, potential collaboration exploration, and a Demo day. The companies will explore partnership opportunities with Siemens Healthineers, Qiagen, Beurer, and Aidian.
PartnersCustomers
Growth-Positive
Wearable tech and portable imaging devices to revolutionize medical sector
The Sheba Medical Center in Tel Aviv, Israel, is fostering medical innovation by collaborating with startups to develop new healthcare technologies. The hospital has launched ARC, a global ecosystem aimed at developing and implementing solutions like wearable technology and portable imaging devices. The center has showcased studies by two companies, Ultrasight and AISAP, that have developed cardiology technology. Another startup, Seamless Vision, is expanding the development of pharmaceutical transport robots for use in large hospitals. Other companies involved in the initiative include Biobeat, Scopio Laboratory, Pulsenmore, GynTools, and Viz.ai.
PartnersExpand
AISAP Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 26 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
AISAP Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516549888 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | jenny.sotnik@sncentral.org |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-08-26T00:00:00.000Z |
| Created | 2022-09-05T00:00:00.000Z |
| Claimed | Yes |